| Israel | Türkei | Österreich | |
| NanoKnife | von $18,500 | von $9,500 | von $25,000 |
| CyberKnife | von $17,500 | von $4,750 | von $50,000 |
| Enukleation des Tumors auf der Bauchspeicheldrüse | - | von $10,000 | - |
| Aktinium-225-Therapie | - | von $22,955 | von $55,000 |
Dr. Pelles Sharon ist auf neuroendokrine Pankreastumoren spezialisiert und bietet im Sourasky Medical Center fortschrittliche Behandlungen wie die Whipple-Operation und HIPEC an.
Prof. Merimsky leitet die Abteilung für Weichteil- und Knochenonkologie am Sourasky Medical Center – Israels größtes Programm für Sarkome.
Dr. Arnon Nagler ist ein international anerkannter Hämatologe und Experte für Knochenmarktransplantationen. Er ist Professor für Medizin an der Universität Tel Aviv. Am Sheba Medical Center ist er emeritierter Direktor der Hämatologie & Knochenmarktransplantation sowie der Nabelschnurblutbank. Er erwarb seinen M.D. an der Hebrew University–Hadassah und einen M.Sc. in Hämatopoese an der Universität Tel Aviv. Seine Postdoc-Ausbildung absolvierte er an der Stanford University. Er ist fachärztlich in Innerer Medizin und Hämatologie anerkannt.
Er verfügt über mehr als 35 Jahre Erfahrung. Er war Pionier allogener Transplantationsprotokolle mit reduzierter Intensität für maligne und nichtmaligne Erkrankungen. Er gründete Israels erste öffentliche Nabelschnurblutbank und führte die ersten Nabelschnurbluttransplantationen des Landes durch.
Er hatte internationale Führungsrollen inne: Vorsitzender und Co‑Vorsitzender der ALWP der EBMT, stellvertretender Vorsitzender und langjähriges Mitglied von EBMT‑Gremien. Er gehörte dem Vorstand von NetCord/EuroCord an und war deren Schatzmeister. Er ist ein gefragter Referent, hat in Fachzeitschriften wie Blood und Leukemia umfangreich publiziert, leitete als Principal Investigator große klinische Studien und übernahm redaktionelle Funktionen. Für Innovation und klinische Exzellenz erhielt er zahlreiche Auszeichnungen.
Prof. Ido Nachmany leitet die Zweite Chirurgische Abteilung am Sheba Medical Center. Er ist spezialisiert auf hepato-pankreato-biliäre (HPB) und robotische Chirurgie bei Erkrankungen der Leber, des Pankreas und der Gallenwege sowie bei gastrointestinalen neuroendokrinen Tumoren. Er führt zudem Operationen an Nebenniere, Milz und Magen durch. Forbes zählte ihn zu Israels Top-Ärzten.
Er fördert minimalinvasive robotische und laparoskopische Techniken. Ziel sind höhere Präzision und schnellere Genesung.
Qualifikationen: Senior Lecturer an der Universität Tel Aviv. Mitglied der ASTS und der IHPBA. Fellowships in HPB- und abdomineller Transplantationschirurgie am Thomas E. Starzl Transplantation Institute. Zertifiziert in Allgemeinchirurgie (Israel), Transplantation abdomineller Organe (ASTS) und HPB-Chirurgie (an der University of Pittsburgh). Er hat in Cancer Research, dem Journal of the American College of Surgeons und dem European Journal of Surgical Oncology publiziert.
Advanced therapies for pancreatic neuroendocrine tumors in Israel include Peptide Receptor Radionuclide Therapy (PRRT) with Lutetium-177 and Actinium-225. Specialized centers perform robotic Whipple procedures and NanoKnife ablation. These facilities maintain JCI accreditation and utilize multidisciplinary tumor boards for personalized treatment protocols.
Bookimed Expert Insight: Israeli oncology centers like Sheba Medical Center often lead in combining PRRT with immunotherapy. Dr. Inna Ospovat at Sourasky Medical Center pioneered PRRT in the region. This clinical experience allows patients to access complex protocols unavailable in most countries. Our data shows Sheba offers comprehensive Whipple surgery packages for approximately $40,000.
Patient Consensus: Patients highlight that Israeli centers provide significantly faster access to PRRT compared to European facilities. Many emphasize the importance of using mouth rinses and staying hydrated to manage specific therapy side effects.
Surgery is the primary curative treatment for localized pancreatic neuroendocrine tumors in Israel. Specialized oncology centers follow international protocols, prioritizing surgical resection for functional or large tumors. JCI-accredited facilities perform complex procedures using minimally invasive robotic and laparoscopic techniques to maximize organ preservation.
Bookimed Expert Insight: Israeli surgical expertise in pNETs is highly concentrated in high-volume public centers like Sourasky and Sheba. Dr. Joseph Klauzner at Sourasky and Dr. Ido Nachmany at Sheba are recognized for performing thousands of complex gastrointestinal surgeries. Choosing these high-volume experts is vital as surgical experience directly correlates with the success of pancreatic resections.
Patient Consensus: Patients note that for small, non-functional tumors, doctors may suggest active monitoring rather than immediate surgery. For those undergoing the Whipple procedure, patients emphasize preparing for a longer recovery and potential long-term digestive changes.
Sheba Medical Center, Sourasky Medical Center, and Hadassah Medical Center are the primary Israeli hospitals for pancreatic neuroendocrine tumors. These JCI-accredited facilities offer European Neuroendocrine Tumor Society (ENETS) certified care. They specialize in high-precision treatments like Peptide Receptor Radionuclide Therapy (PRRT) and robotic Whipple surgery.
Bookimed Expert Insight: While many choose Sheba for its global rank 7 ranking, the real value lies in its specialized genetic counseling. Our data shows Sheba provides specific screening for familial syndromes like MEN1 and VHL. This is vital because these mutations often cause recurrent tumors that require long-term monitoring rather than a single surgery. If your family history is unclear, starting with their endocrine bioinformatics lab can refine your entire treatment roadmap.
Patient Consensus: Patients emphasize finding a surgeon who performs over 20 NET cases annually to avoid common post-surgical complications. Many note that outcomes improved significantly when they ensured an endocrinologist was part of the initial tumor board decision.
Verify a physician’s experience in Israel by checking board certifications in oncology or endocrinology. Confirm affiliations with centers like Sheba Medical Center or Sourasky Medical Center. Specialist expertise in pancreatic neuroendocrine tumors is often validated through published research in peer-reviewed journals.
Bookimed Expert Insight: Israeli specialists often hold dual roles in clinical care and national health policy. For example, Dr. Ido Wolf chairs the National Council for Malignant Diseases. Choosing a physician with such leadership status ensures your treatment plan follows the newest updated protocols.
Patient Consensus: Patients suggest searching medical databases for a surgeon's name to see their case volumes. It is also helpful to check if your doctor trained at global centers like the Mayo Clinic.
International patients seeking processing for pancreatic neuroendocrine tumors in Israel receive logistics coordination through dedicated departments. These teams manage medical visa invitations for urgent treatments like PRRT or Whipple surgery. Support includes multilingual case management and remote record reviews at JCI-accredited centers.
Bookimed Expert Insight: While Sheba Medical Center ranks among the top 10 globally, its pNET surgical packages, such as those with Dr. Professor Ido Nachmany, often exclude lodging and transfers despite the $40,000 price. Patients should budget for 14 nights at a local hotel to ensure proper recovery after a 6-day hospital stay.
Patient Consensus: Patients note it's important to contact international departments at least 3 months early for visa letters. They also emphasize arranging private accommodation near clinics like Hadassah through platforms like Airbnb to manage costs.